Key Ingredients
Medicare Part D cannot cover drugs used strictly for weight loss, though a GLP-1 may be covered for a qualifying condition like diabetes
FDA Warning Letter to Glicerinas Industriales, S.A
Regardless of the form of the drug you take, your doctor will recommend you combine it with increased physical activity and a balanced diet to experience the drugs full effects

Disclosures: Rajan Vijayaraghavan: Nothing to Disclose, Ankit Bharadwaj: Nothing to Disclose, Vinod Arora: Nothing to Disclose, Gaurav Sidhwani: Nothing to Disclose, Uma Kanal: Nothing to Disclose, Rakhi Maiwall: Nothing to Disclose, Ashok Kumar Choudhury: Nothing to Disclose, Harsh Tevethia: Nothing to Disclose, Jaya Benjamin: Nothing to Disclose, Satender Pal Singh: Nothing to Disclose, CHITRANSHU VASHISHTHA: Nothing to Disclose, Manoj Sharma: Nothing to Disclose, Shiv Kumar Sarin: Nothing to Disclose 2594 IMPACT OF LAPAROSCOPIC SURGERY VERSUS OPEN SURGERY ON LONG-TERM OUTCOMES AND HEALTHCARE UTILIZATION IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AND SEVERE OBESITY Xinrong Zhang 1 Nicholas Rouillard 1 Xianhua Mao 2 Rongtao Lai 3 Ramsey Cheung 4 Kazunari Sasaki 5 , 1 Division of Gastroenterology and Hepatology, School of Medicine, Stanford University, 2 Department of Medicine, School of Clinical Medicine, The University of Hong Kong, 3 Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 4 Stanford University Medical Center, 5 Department of Surgery, School of Medicine, Stanford University Background: Bariatric surgery has been recognized as a potential treatment for patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity
